Trial · NCT00395291
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in IGF-1 After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the IGF-1 levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Acyl-Ghrelin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention. | Looking for a change in the Acyl-Ghrelin levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Leptin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Leptin levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Insulin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Insulin levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Des-Acyl Ghrelin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Des-Acyl Ghrelin levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in TNF-alpha After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the TNF-alpha levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in CRPs After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the CRPs levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in IL-1 After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the IL-1 levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Changes in the Following Level: IL-6 | After the subject has comleted their last visit | Change in IL-6 after 30 days of intervention. |
| Secondary | Change in IL-10 After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the IL-10 levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Esterase After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Esterase levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Adiponectin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Adiponectin levels after the subject has been on intervention for 30 days compared to baseline levels. |
| Secondary | Change in Ghrelin After 30 Days of Intervention Compared to Baseline Level. | Baseline and after 30 days of intervention | Looking for a change in the Ghrelin levels after the subject has been on intervention for 30 days compared to baseline levels. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00395291/registered